hsk39297
Small moleculeexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Dec 25, 2023 (NCT06350279)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07152288 | Phase 1 | May 29, 2025 | Haisco Pharmaceutical |
| NCT07052838 | Phase 3 | May 12, 2025 | Haisco Pharmaceutical |
| NCT06799546 | Phase 3 | Feb 20, 2025 | Haisco Pharmaceutical |
| NCT06745622 | Phase 2 | Jan 3, 2025 | Haisco Pharmaceutical |
| NCT06670352 | Phase 2 | Oct 12, 2024 | Haisco Pharmaceutical |
| NCT06852092 | Phase 1 | Sep 9, 2024 | Haisco Pharmaceutical |
| NCT06561841 | Phase 2 | Jul 17, 2024 | Haisco Pharmaceutical |
| NCT06350279 | Phase 1 | Dec 25, 2023 | Haisco Pharmaceutical |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haisco Pharmaceutical | For profit | 8 | 8 | 3 | 2023 |
1 organizations
Page 1 / 1